Teva Pharmaceutical Industries Limited Stock price TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 5,813B | Sales 2025 * | 16.28B 5,970B | Capitalization | 15.82B 5,799B |
---|---|---|---|---|---|
Net income 2024 * | 420M 154B | Net income 2025 * | 743M 272B | EV / Sales 2024 * | 1.92 x |
Net Debt 2024 * | 14.62B 5,361B | Net Debt 2025 * | 12.12B 4,443B | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
19.5
x | P/E ratio 2025 * |
15.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.57% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |